Just as an extra note. As the data is from a double-blinded, placebo trial. No data should be publicly available until after the trial has concluded.
The 2a and 2b cohorts are apart of the same trial and data from both cohorts should be available hopefully by April.
I can understand where there could be confusion as they have referred to the same trial with multiple titles.
I think it would be easier to follow if the trial was consistently referred to its technically suitable 'phase 2a/b trial' title and the '2a cohort' and '2b cohort' when discussing those cohorts individually.
ILA Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)